Mylan to create 500 Jobs
Wednesday, April 18, 2012
IDA Ireland today announced an important investment initiative to expand Mylan’s operations in Dublin and Galway.
Through Mylan’s annual investment of up to €76 million ($100 million) over the next five years, including funding for expanded research and development (R&D) capabilities, and support from the Irish government through IDA, Mylan will add more than 500 new positions to its Ireland-based workforce by 2016.
Mylan currently is the largest generics pharmaceutical manufacturer in Ireland and one of the world’s leading pharmaceutical companies. The IDA is the Irish agency responsible for attracting foreign direct investment to the country.
Taoiseach Kenny said: “Mylan’s decision to expand in both Dublin and Galway is most welcome news. Mylan is a key member of the Irish pharmaceutical sector and one of the top suppliers in the country, providing the market with high quality generic pharmaceuticals and over-the-counter medicines. Today’s announcement, in addition to the company’s proven, 25-year track record as a top employer and reliable exporter in Ireland, demonstrates Mylan’s commitment to its Irish operations and recognition for the capabilities of its talented workforce. I would like to offer continued support of the Irish government, and IDA Ireland, to Mylan as it continues to grow in our country and as it further serves as an innovative contributor to the Irish economy.’’
Mylan currently employs about 700 people at its facilities in Ireland. The planned expansion of Mylan’s operations in Ireland involves R&D and manufacturing capabilities within the company’s respiratory, injectables and oral solids franchises.
Of the 500 Mylan jobs to be added by 2016, about 220 will be based in Galway with the remainder in Dublin. Mylan’s operations in Ireland include Gerard Laboratories and Bioniche Pharma. For more information about Mylan, please visit http://www.mylan.com. IDA Ireland